Via Scoop.it – Virology News
ROCKVILLE, Md. — Novavax, Inc. today announced that it has begun enrollment in a Phase II clinical trial of its quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate. This randomized, …
- Comment
- Reblog
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
ViroBlogy 
Leave a comment